← All indications
Endometrial Hyperplasia
Benign proliferation of the ENDOMETRIUM in the UTERUS. Endometrial hyperplasia is classified by its cytology and glandular tissue. There are simple, complex (adenomatous without atypia), and atypical hyperplasia representing also the ascending risk of becoming malignant.
Drugs by status
Approved for this indication (3)
Phase 4 trials (4)
Phase 3 trials (12)
Phase 2 trials (8)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (6)
Organization Involved with Phase 3 Indications (7)
Organization Involved with Phase 2 Indications (15)
- Novartis
- National Cancer Institute (NCI)
- National Heart, Lung, and Blood Institute (NHLBI)
- Brown University
- Cairo University
- Gynecologic Oncology Group
- New York University
- University of Messina
- University of Southern California
- Tel Aviv University
- University of Queensland
- University of Texas at Houston
- University of Wisconsin
- Queensland University of Technology
- Ferring
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (2)